| Pharmaceutical Information |
| Drug Name |
Propantheline bromide |
| Drug ID |
BADD_D01861 |
| Description |
A muscarinic antagonist used as an antispasmodic, in rhinitis, in urinary incontinence, and in the treatment of ulcers. At high doses it has nicotinic effects resulting in neuromuscular blocking. |
| Indications and Usage |
For the treatment of enuresis. It has also been used for hyperhidrosis, and cramps or spasms of the stomach, intestines or bladder. |
| Marketing Status |
approved |
| ATC Code |
A03AB05 |
| DrugBank ID |
DB00782
|
| KEGG ID |
D00481
|
| MeSH ID |
D011413
|
| PubChem ID |
9279
|
| TTD Drug ID |
D0V5ZZ
|
| NDC Product Code |
58159-065; 43744-457 |
| UNII |
UX9Z118X9F
|
| Synonyms |
Propantheline | Propantheline Bromide | Bromide, Propantheline | Probanthine | Pro-Banthine | Pro Banthine |
|
| Chemical Information |
| Molecular Formula |
C23H30NO3.Br |
| CAS Registry Number |
50-34-0 |
| SMILES |
CC(C)[N+](C)(CCOC(=O)C1C2=CC=CC=C2OC3=CC=CC=C13)C(C)C.[Br-] |
| Chemical Structure |
|
|
| ADRs Induced by Drug |
|
|
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
|
|
|
